The AST responsible for a raised enzyme activity, with otherwise normal biochemistry, in a single individual over a 16-month period has been characterized as an IgG (l)-AST complex by (i) estimation of the molecular size by gel exclusion chromatography on Sephadex G200, (ii) agarose gel electrophoresis, (iii) immunoprecipitation by anti-immunoglobulin antisera and (iv) adsorption on to protein Aagarose, Circulating macromolecular complexes have been reported for a variety of enzymes, including amylase, lactate dehydrogenase, creatine kinase, alanine aminotransferase and alkaline phosphatase' and, more recently a macrolipase has been described.! There have been nine reported cases (and two cited) of a raised AST activity due to an enzyme complex.>? predominantly AST complexed with IgG. Of the nine cases, most were subjectively healthy individuals with no liver, heart or muscle disease on clinical or pathological grounds.
We wish to describe the laboratory investigation of an AST that was measured at approximately 300 IU/L over a 16-month period with otherwise normal biochemistry.
Case history
The patient (ST) was a 36-year-old woman who presented to her general practitioner with mild abdominal pain in September 1987. A general biochemistry profile revealed AST of 278 IU/L (NR 13-34: Parallel, American Monitor (UK) Ltd, Burgess Hill, UK) and no other abnormality, Referrals to a gynaecologist and then a gastroenterologist for investigation produced a tentative diagnosis of irritable bowel syndrome. There was no history of liver or cardiac disease. Since October 1987 her serum AST has been measured using the American Monitor activated AST method based on IFCC recommendations! on nine occasions and found to be between 271
t Division of Medicine, United Norwich Hospitals.
538
and 398 IU/L. All other biochemistry was normal including alanine aminotransferase, alkaline phosphatase, gamma glutamyl transferase, lactate dehydrogenase, total creatine kinase and CKMB.
Materials and methods
Serum samples from three patients with appropriately raised AST activities were used for comparison. The AST activities were 412, 302 and 1475 IU /L from patients with liver disease (control I), a myocardial infarction (control II) and a myocardial infarction with liver disease (control III) respectively. These samples were investigated alongside the patient's (ST) serum as controls.
GEL EXCLUSION CHROMATOGRAPHY
Serum samples (200 JlL) were applied to a Sephadex G200 column (14 ern x l em diameter) and the AST activity eluted with 50 rnmol/L Tris-HCI buffer pH 7-4 at room temperature with a flow rate of 0·4 crnvmin. The void volume was checked using blue dextran.
ELECTROPHORESIS
AST isoenzymes were separated by electophoresis of 0·6 JlL of serum on Corning Universal agarose gels at 90 V for 20 min using 50 rnmol/L barbitone buffer pH 8·6. Enzyme activity was identified by incubating the gel at 37°C for 30 min with an overlay of 1 em! of standard American Monitor AST reagents and drying the gel at 60°C for 20 min. The AST isoenzymes can be seen under u.v. light as dark bands on a fluorescent background.
FIG.2. Electrophoresis ofAST isoenzyme bands from
control II and (iv) control I sera. The mitochondrial band was barely visible to the naked eye.
PRECIPITATION WITH ANTISERA TO IMMUNOGLOBULINS Anterisera to 19A, IgM and IgG (Atlantic Antibodies, Winnersh, UK) were diluted in the Tris-HCI buffer and 20 pL of the diluted antisera or buffer was incubated with 20 pL ofserum at room temperature for 30 min. To aid precipitation, 40 pI of 3% polyethylene glycol was added and after 30 min the samples were centrifuged (MSE Microcentaur) for I min and AST activity was assayed in the supernatant. Antisera (undiluted) to" and Alight chains (Atlantic Antibodies) were incubated with serum samples and treated in the same way.
PROTEIN A-AGAROSE ADSORPTION Protein A-agarose (Sigma Chemical Co., Poole, UK) was swollen in the Tris-HCI buffer (80 mg in 0·4 em') and 60 pL of the swollen gel or 60 pL of buffer was incubated with 50 pL of serum for 60 min at room temperature. After centrifugation, AST activity was measured in the supernatant. seen in the ST serum elution profile. The two other control serum samples with raised AST had a peak coincident with the control shown in Fig.  I . Two other ST samples taken three months apart and stored frozen showed the same behaviour on G200, including the small shoulder.
Electrophoresis separates the mitochondrial and cytosolic isoenzymes of AST. Figure 2 is a photograph of an agarose gel of the controls and ST samples. All three controls had the cytosolic enzyme which moves anodally and control I and III also had the mitochondrial enzyme. The serum samples from ST had a band running between the other two isoenzymes as well as a small amount of the cytosolic isoenzyme. 
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Results
The Sephadex G200 elution profiles of AST from ST serum and a control serum are shown in Fig. I . In the control, the AST is retarded by the G200, whereas in the ST sample the activity came through in the void volume. A small shoulder in the same position as the AST in the control can be Antiserum to IgG precipitated 30% of the AST activity from ST serum whereas 19A and IgM antisera had no effect (Fig. 3a) . None of the immunoglogulin antisera precipitated AST activity in any of the three control serum samples (lgG shown in Fig. 3b ). Antiserum to IC light chains had no effect on the AST activity in the controls or ST serum samples whereas anti 1 precipitated 60% of AST in ST serum but did not affect AST in the controls.
AST activities left after adsorption with Protein A-agarose in the controls and ST serum samples are shown in Table 1 . Approximately 90% of ST serum AST was adsorbed on to Protein A-agarose while the control AST activities were unaffected. One other ST sample was treated with Protein A-agarose with similar results. Increasing the amount of Protein A used removed no more AST from ST serum.
Discussion
The reported molecular weight of AST is approximately 90 000 daltons and two isoenzymes can be separated by electrophoresis, the anodally migrating cytosolic one and a mitochondrial one which migrates towards the cathode. Serum AST is usually the cytosolic isoenzyme, the mitochondrial isoenzyme being seen only in severe tissue damage.
The behaviour of AST from the three control serum samples on Sephadex G200 is consistent with a molecular weight of 90000 daltons whereas that of the patient's (ST) AST is greater than 200000 daltons (see Fig. I ). Immunochemical precipitation studies (Fig, 3a and b) and specific adsorption ofIgG by protein A (Table I) indicate that this large molecular weight molecule is an IgG (l)-AST complex. Electrophoresis showed all the control sera to have the cytosolic AST and two had the mitochondrial isoenzyme (Fig. 2) . The IgG-AST complex in ST serum migrates between the two isoenzymes and, from the position on the gel, the AST in the complex is probably the cytosolic isoenzyme. The shoulder in the G200 elution profile, the residual activity after Protein A adsorption and the faint band on electrophoresis (Fig. 2) indicate the ST serum contains a small amount of uncompiexed AST, in addition to the complex.
One of the nine reported cases of an AST complex had lung carcinoma with liver metastases with the macro AST being a minor component of the total AST.4 Of the other eight cases (six women, and two men), the patients were subjectively healthy but underwent extensive investigations including liver biopsy. The patient reported here had nine hospital visits, the last six of which were to 'keep an eye on her raised AST' . 9 This laboratory performed an average of 7469±461 AST tests per month in 1988and as far as we are aware the patient (ST) is the first persistently raised AST to be seen since at least 1974. Clearly, IgG-AST complexes are less common than circulating complexes for amylase, creatinine kinase and lactate dehydrogenase. Nonetheless, clinicians and laboratory staff should be aware of the possible presence of macro AST to avoid unnecessary investigations.
